RAP
Click for more information
0.00% 20.5¢ resapp health limited

Technically speaking this isn't true, it is a requirement of...

  1. Mcfisty
    272 Posts.
    lightbulb Created with Sketch. 52
    clock Created with Sketch.
    08/12/20
    16:37
    Post #: 49428252
    Technically speaking this isn't true, it is a requirement of clinical evaluation and risk analysis by European regulations. The key difference is that European regulators look a lot less closely at the actual clinical data, and more closely at the evaluation process used by manufacturers.
    RAP Price at posting: 9.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.